The Medical Director will design and execute clinical development strategy for Jounce’s lead immune-oncology product candidate, JTX-2011, an agonist antibody to ICOS. He or she will be responsible for all clinical activities related to JTX-2011 sponsored studies. As Jounce grows and brings new drugs into the clinic, there will be an opportunity to take on more responsibility and play an important leadership role in the company.
Major Responsibilities include:
Qualification and Education Requirements:
To apply, please visit our website at https://careers-jouncetx.icims.com